George Golumbeski is a director of Sage Therapeutics Inc.
Person profile
Roles
Sage Therapeutics
Director
Shattuck Labs
Director
Address
Summit, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sage Therapeutics, Inc.
4 Jan 24
4
Sage Therapeutics, Inc.
16 Jun 23
4
Shattuck Labs, Inc.
31 May 23
4
Sage Therapeutics, Inc.
5 Jan 23
4
Sage Therapeutics, Inc.
17 Jun 22
4
Shattuck Labs, Inc.
10 Jun 22
4
Sage Therapeutics, Inc.
9 May 22
4
Shattuck Labs, Inc.
27 Apr 22
4
Shattuck Labs, Inc.
26 Apr 22
4
Sage Therapeutics, Inc.
5 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 24 | SAGE Sage Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 21.67 | 3,495 | 75.74 k | 3,495 |
15 Jun 23 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 56.1 | 10,000 | 561.00 k | 10,000 |
26 May 23 | STTK Shattuck Labs | Stock Option Common Stock | Grant | Acquire A | No | No | 2.72 | 40,258 | 109.50 k | 40,258 |
4 Jan 23 | SAGE Sage Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 39.16 | 2,108 | 82.55 k | 2,108 |